Medical Device Testing Market
Global Industry Analysis and Forecast 2023-2030
Market Value (2022)
USD 9.12 Billion
Forecasted Value (2030)
USD 15.84 Billion
CAGR (2023 - 2030)
Fastest Growing Region (2023 - 2030)
Testing, Inspection, Certification, Others
By Device Class
Class I, Class II, Class III
Active Implant Medical Device, Active Medical Device, Non-active Medical Device, In Vitro Diagnostic Medical Device, Ophthalmic Medical Device, Orthopedic and Dental Medical Device, Others
The global Medical Device Testing Market was valued at USD 9.12 billion in 2022 and is projected to reach USD 15.84 billion by 2030, growing at a CAGR of 8.20% from 2023 to 2030.
The market is being strongly influenced by stringent government regulations, the emergence of numerous small medical device companies lacking internal expertise, and a growing demand for comprehensive verification and validation of medical devices. These factors collectively drive the growth and evolution of the medical device testing market. The regulatory landscape forces companies to comply with rigorous standards, ensuring safety, efficacy, and quality of their products. The influx of smaller players in the industry, while promoting innovation, often faces challenges in navigating complex regulatory requirements and achieving compliance. Additionally, the increased emphasis on verification and validation processes reflects the industry's commitment to delivering reliable and effective medical devices. This dynamic environment presents opportunities for companies specialized in offering regulatory consulting, testing, and verification services to cater to the growing needs of the market.
Analyst’s Review on the Medical Device Testing Market
The medical device testing market is influenced by several trends. Firstly, there is a growing concern regarding the presence of harmful substances like BPA and phthalates in medical devices and other mass-produced products. This has led to an increased focus on rigorous testing and regulatory compliance. Additionally, the market is witnessing a rise in the number of small medical device companies lacking in-house expertise, leading to an increased demand for outsourced testing services. Furthermore, there is a growing emphasis on quality assurance and validation processes for medical devices to ensure safety and efficacy. These trends collectively shape the landscape of medical device testing, creating opportunities for specialized testing providers to cater to the evolving needs of the industry.
Medical device testing is the process of evaluating and assessing the safety, quality, and performance of medical devices before they are approved for market release. This rigorous testing ensures that these devices meet regulatory standards, perform reliably, and are safe for use by healthcare professionals and patients. It plays a critical role in the development and evaluation of a wide range of medical devices, including diagnostic tools, therapeutic equipment, monitoring devices, and implants.
One of the main advantages of medical device testing is its focus on ensuring patient safety. Through comprehensive testing procedures, potential hazards and risks associated with the device can be identified and addressed by manufacturers. This allows for enhancements in device design and functionality, ultimately minimizing potential harm to patients and improving overall safety.
However, there are various applications of medical device testing across different areas of healthcare. In diagnostics, testing is crucial for devices such as imaging systems, laboratory equipment, and point-of-care devices. These tests ensure the accuracy and reliability of diagnostic results, assisting healthcare professionals in disease detection, monitoring, and treatment planning.
Medical device testing is also essential for monitoring and wearable devices. Whether it be wearable medical devices, remote monitoring systems, or home healthcare devices, testing is conducted to assess the accuracy of data capture, transmission, and the ability to measure vitals accurately. This enables patients and healthcare providers to make informed decisions based on reliable and real-time feedback.
The increasing need for validation and verification for medical devices is a significant driver of market growth in the medical device testing industry. The stringent regulatory requirements and the emphasis on patient safety necessitate thorough testing and certification of medical devices. As the demand for advanced and quality medical products rises, manufacturers are under pressure to ensure their devices meet the necessary standards. This has led to a growing reliance on testing services to validate the performance, functionality, and safety of medical devices. Additionally, the need for verification and validation is fueled by the increasing complexity of medical devices and the desire to mitigate risks associated with their use. As a result, the medical device testing market is expected to experience continued growth as companies seek specialized testing and certification services to comply with regulations and demonstrate product quality, and is likely to continue to have a significant impact on the industry in the future.
Medical device testing encounters several challenges that necessitate efficient resolution to guarantee the safety, efficacy, and reliability of these devices. Key challenges encompass the need to ensure seamless compatibility with diverse systems, mitigate the risks of security breaches, conduct rigorous testing for durability and fatigue resistance, and meet stringent regulatory standards. Furthermore, the intricacies of testing software components, encompassing interoperability and reliability, add an additional layer of complexity. By effectively addressing these challenges, businesses can ensure the successful testing and deployment of medical devices that adhere to regulatory requirements and engender confidence in their performance and safety.
The global medical device testing market is segmented based on service, sourcing, device class, technology, and geography.
Based on the service, the market is categorised into testing, inspection, certification, and others. The testing segment held the largest revenue share due to the increasing demand in the medical device industry can be attributed to the industry's growing emphasis on delivering high-quality and compliant products. These services play a crucial role in ensuring that medical devices meet the required regulatory standards for quality, safety, and performance. Examples of testing services include comprehensive evaluations such as electro-medical device testing, biocompatibility testing, clinical research services, and assessments of materials and device performance. These services are typically conducted in specialized laboratories and research sites.
Based on sourcing, the medical device testing market is divided into in-house and outsourced. The outsourced segment is anticipated to be the fastest-growing CAGR over the forecast period. Large companies are opting to outsource their medical device testing services due to the rising costs associated with conducting in-house tests, driven by increased regulations. By outsourcing these services to third-party vendors, businesses can effectively reduce the overall expenses related to testing. This trend is particularly prominent for technologies like active implant medical devices, which require significant capital investment for in-house testing activities. The outsourcing of testing, inspection, and certification (TIC) services allows companies to optimize their resources and focus on core competencies while ensuring compliance with regulatory requirements.
By device class, the medical device testing market is divided into Class I, Class II, and Class III. The Class III segment is expected to be the fastest-growing region over the forecast period owing to the demand for the classification of medical devices is on the rise due to the acknowledgment of potential risks involved in their usage and the growing concerns of patients. Class III medical devices, which are crucial for sustaining and supporting human life, are regarded as high-risk devices and subjected to rigorous regulatory oversight. Typically, these devices require approval from regulatory bodies, such as the FDA, prior to market entry. Examples of Class III devices include implantable pacemakers, replacement heart valves, and pulse generators. The classification process ensures that these devices meet stringent safety and efficacy requirements, providing assurance to both healthcare providers and patients.
Based on region, the global medical device testing market is classified into North America, Europe, Asia Pacific, MEA, and Latin America.
North America dominated the market in 2022 owing to the escalating intricacies in product design and the relentless pursuit of cost reductions. Additionally, the market is being propelled by the presence of robust regulatory bodies, notably the FDA, which ensures compliance and safety standards. The rapid expansion of medical device manufacturing in response to the region's mounting demand for effective healthcare is also a significant catalyst for market growth in North America. These factors collectively contribute to the positive trajectory of the market, paving the way for increased innovation, efficiency, and accessibility in the healthcare sector across the region.
Additionally, the Food and Drug Administration (FDA) granted Emergency Use Authorizations (EUA) for medical devices utilized in diagnosing COVID-19, as well as personal protective equipment (PPE) necessary for safeguarding healthcare providers while interacting with patients during the COVID-19 pandemic in 2020, in the United States.
The global medical device testing industry report will provide valuable insight with an emphasis on the fragmented nature of the global market. Prominent players are focusing on several key business strategies such as partnerships, mergers and acquisitions, product innovations, and joint ventures to expand their product portfolio and increase their market shares across different regions. Expansion & investments involve a range of strategic initiatives including investments in R&D activities, new manufacturing facilities, and supply chain optimization which could pose new opportunities for the market. The major manufacturers in the medical device testing market are
- Nelson Laboratories, LLC (Sotera Healthm)
- The British Standards Institution
- Element Materials Technology
- Eurofins Scientific
- Pace Analytical Services, LLC
- SGS SA
- ITC ZLÍN
- April 2023 (Certification): Nelson Labs, a renowned provider of microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical sectors, recently achieved ASCA accreditation as a biocompatibility testing laboratory by the U.S. Food and Drug Administration (FDA).
- March 2023 (Partnership): Nemera and Nelson Labs Europe announced a partnership aimed to provide customers with comprehensive integrated services including leachables, extractables, microbiology, biocompatibility, and chemical testing.
- March 2023 (Acquisition): Pace Analytical Services completed the acquisition of Alpha Analytical to strengthen and expand its portfolio of offerings to better accommodating client needs in the environmental testing and analysis sector. By combining its resources and expertise, Pace Analytical Services intends to enhance its capabilities and provide even greater value to customers.
- July 2022 (Acquisition): SGS acquired Proderm, a premier company in Germany offering sophisticated clinical testing solutions for cosmetics, personal care, and medical products.
- December 2021 (Acquisition): Labcorp acquired Toxikon Corporation, which specializes in nonclinical testing services to strengthen its nonclinical development portfolio and to establish a strategic presence in Boston, Massachusetts through collaborations with pharmaceutical and biotechnology clients.
The global Medical Device Testing Market is segmented as:
By Device Class
- Class I
- Class II
- Class III
- Active Implant Medical Device
- Active Medical Device
- Non-active Medical Device
- In Vitro Diagnostic Medical Device
- Ophthalmic Medical Device
- Orthopedic and Dental Medical Device
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- North Africa
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Rest of Latin America